2020 Q1 Form 10-Q Financial Statement

#000082414220000090 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $137.5M $113.8M
YoY Change 20.79% 14.88%
Cost Of Revenue $94.54M $88.39M
YoY Change 6.95% 5.37%
Gross Profit $42.95M $25.43M
YoY Change 68.88% 67.35%
Gross Profit Margin 31.24% 22.34%
Selling, General & Admin $15.21M $13.68M
YoY Change 11.24% 17.39%
% of Gross Profit 35.43% 53.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.002M $5.914M
YoY Change 1.49% 43.23%
% of Gross Profit 13.98% 23.26%
Operating Expenses $15.21M $13.68M
YoY Change 11.24% 17.39%
Operating Profit $27.80M $11.47M
YoY Change 142.35% 222.89%
Interest Expense $100.0K $0.00
YoY Change -100.0%
% of Operating Profit 0.36% 0.0%
Other Income/Expense, Net -$27.00K -$26.00K
YoY Change 3.85% 333.33%
Pretax Income $27.83M $11.45M
YoY Change 143.01% 216.88%
Income Tax $5.976M $2.695M
% Of Pretax Income 21.47% 23.53%
Net Earnings $21.85M $8.757M
YoY Change 149.55% 177.65%
Net Earnings / Revenue 15.9% 7.69%
Basic Earnings Per Share $0.42 $0.17
Diluted Earnings Per Share $0.41 $0.17
COMMON SHARES
Basic Shares Outstanding 52.07M shares 51.99M shares
Diluted Shares Outstanding 52.87M shares 52.37M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.70M $7.100M
YoY Change 402.82% -69.26%
Cash & Equivalents $35.68M $7.143M
Short-Term Investments
Other Short-Term Assets $18.50M $1.600M
YoY Change 1056.25% 33.33%
Inventory $72.86M $74.58M
Prepaid Expenses
Receivables $69.89M $58.69M
Other Receivables $0.00 $4.800M
Total Short-Term Assets $197.0M $146.5M
YoY Change 34.44% -5.14%
LONG-TERM ASSETS
Property, Plant & Equipment $193.0M $166.7M
YoY Change 15.83% 12.66%
Goodwill $3.229M $3.229M
YoY Change 0.0% -12.18%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $198.7M $172.7M
YoY Change 15.01% 13.44%
TOTAL ASSETS
Total Short-Term Assets $197.0M $146.5M
Total Long-Term Assets $198.7M $172.7M
Total Assets $395.6M $319.2M
YoY Change 23.93% 4.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.50M $5.947M
YoY Change 127.02% -73.23%
Accrued Expenses $50.68M $38.05M
YoY Change 33.19% 8.48%
Deferred Revenue $2.256M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.19M $43.08M
YoY Change 48.98% -23.86%
LONG-TERM LIABILITIES
Long-Term Debt $6.300M $0.00
YoY Change
Other Long-Term Liabilities $3.700M $3.400M
YoY Change 8.82% 112.5%
Total Long-Term Liabilities $10.00M $3.400M
YoY Change 194.12% 112.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.19M $43.08M
Total Long-Term Liabilities $10.00M $3.400M
Total Liabilities $89.30M $60.20M
YoY Change 48.34% -10.55%
SHAREHOLDERS EQUITY
Retained Earnings $306.1M $258.2M
YoY Change 18.56% 7.85%
Common Stock $208.0K $208.0K
YoY Change 0.0% -0.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $306.3M $259.4M
YoY Change
Total Liabilities & Shareholders Equity $395.6M $319.5M
YoY Change 23.82% 4.1%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $21.85M $8.757M
YoY Change 149.55% 177.65%
Depreciation, Depletion And Amortization $6.002M $5.914M
YoY Change 1.49% 43.23%
Cash From Operating Activities $37.60M $14.91M
YoY Change 152.11% 38.8%
INVESTING ACTIVITIES
Capital Expenditures -$21.90M -$8.800M
YoY Change 148.86% 3.53%
Acquisitions
YoY Change
Other Investing Activities $100.0K $100.0K
YoY Change 0.0% -100.83%
Cash From Investing Activities -$21.80M -$8.703M
YoY Change 150.53% -57.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$8.021M -$1.061M
YoY Change 655.98% -70.58%
NET CHANGE
Cash From Operating Activities $37.60M $14.91M
Cash From Investing Activities -$21.80M -$8.703M
Cash From Financing Activities -$8.021M -$1.061M
Net Change In Cash $7.772M $5.149M
YoY Change 50.94% -138.76%
FREE CASH FLOW
Cash From Operating Activities $37.60M $14.91M
Capital Expenditures -$21.90M -$8.800M
Free Cash Flow $59.50M $23.71M
YoY Change 150.9% 23.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
583-2266
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2425 South Yukon Ave.,
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa,
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74107
CY2020Q1 dei City Area Code
CityAreaCode
918
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000824142
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P1Y
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
0-18953
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
AAON, INC.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0448736
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q1 dei Trading Symbol
TradingSymbol
AAON
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52031532 shares
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35677000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26797000 USD
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
16468000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
17576000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69894000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67399000 USD
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
772000 USD
CY2020Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
27000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
29000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
72855000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
73601000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2045000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1375000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
196966000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
187549000 USD
CY2020Q1 us-gaap Land
Land
3298000 USD
CY2019Q4 us-gaap Land
Land
3274000 USD
CY2020Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
104707000 USD
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
101113000 USD
CY2020Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
252544000 USD
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
236087000 USD
CY2020Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
17116000 USD
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
16862000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
377665000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
357336000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
184636000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179242000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193029000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
178094000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
213000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
272000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
3229000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3229000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1641000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1683000 USD
CY2020Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
542000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
597000 USD
CY2020Q1 us-gaap Assets
Assets
395620000 USD
CY2019Q4 us-gaap Assets
Assets
371424000 USD
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13501000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11759000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50684000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44269000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
64185000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56028000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15130000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15297000 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1800000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3652000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3639000 USD
CY2020Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
6330000 USD
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
6320000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52044110 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52044110 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52078515 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52078515 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
208000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
208000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3631000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
306115000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
286301000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
306323000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
290140000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
395620000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
371424000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
137483000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
113822000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94536000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
88392000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
42947000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
25430000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15214000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13677000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
62000 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-284000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
27795000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11469000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
61000 USD
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27829000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11452000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5976000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2695000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
21853000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52071839 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51992150 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52871419 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52369660 shares
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
290140000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
21853000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4497000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2351000 USD
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
12518000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
306323000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249443000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4010000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5407000 USD
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
5071000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
262546000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6002000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5914000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
10000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
294000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
115000 USD
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
-274000 USD
CY2019Q1 us-gaap Inventory Write Down
InventoryWriteDown
357000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2351000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5407000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
62000 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-284000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-51000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
16000 USD
CY2020Q1 aaon Interest Income Note Receivable
InterestIncomeNoteReceivable
6000 USD
CY2019Q1 aaon Interest Income Note Receivable
InterestIncomeNoteReceivable
6000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-167000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
909000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2789000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4725000 USD
CY2020Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
772000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1800000 USD
CY2019Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
1432000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1020000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2678000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
670000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
561000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2742000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5730000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
229000 USD
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6241000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
73000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37597000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14913000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
21877000 USD
CY2019Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8772000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
61000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
52000 USD
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
12000 USD
CY2019Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
17000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21804000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8703000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4497000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4010000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
11565000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
4483000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
953000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
588000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8021000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1061000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7772000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5149000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44373000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1994000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52145000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7143000 USD
CY2020Q1 aaon Number Of Variable Interest Entities With Directed Activities
NumberOfVariableInterestEntitiesWithDirectedActivities
2 numberOfVIEs
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Use of Estimates</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Because these estimates and assumptions require significant judgment, actual results could differ from those estimates and could have a significant impact on our results of operations, financial position and cash flows. We reevaluate our estimates and assumptions as needed, but at a minimum on a quarterly basis. The most significant estimates include, but are not limited to, inventory reserves, warranty accrual, worker's compensation accrual, medical insurance accrual, income taxes and share-based compensation. Actual results could differ materially from those estimates.</span></div>
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1600000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1600000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
137483000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
113822000 USD
CY2020Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
12600000 USD
CY2019Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
11500000 USD
CY2020Q1 aaon Extended Product Warranties Minimum Length
ExtendedProductWarrantiesMinimumLength
P6M
CY2020Q1 aaon Extended Product Warranties Maximum Length
ExtendedProductWarrantiesMaximumLength
P10Y
CY2020Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
70541000 USD
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
67752000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
647000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
353000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69894000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67399000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
353000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
264000 USD
CY2020Q1 aaon Allowancefor Doubtful Accounts Receivable Netof Recoveries
AllowanceforDoubtfulAccountsReceivableNetofRecoveries
294000 USD
CY2019Q1 aaon Allowancefor Doubtful Accounts Receivable Netof Recoveries
AllowanceforDoubtfulAccountsReceivableNetofRecoveries
115000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
647000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
379000 USD
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
67815000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
68842000 USD
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2055000 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1825000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5350000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5578000 USD
CY2020Q1 us-gaap Inventory Gross
InventoryGross
75220000 USD
CY2019Q4 us-gaap Inventory Gross
InventoryGross
76245000 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2365000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2644000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
72855000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
73601000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2644000 USD
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1210000 USD
CY2020Q1 aaon Inventory Valuation Reserves Provision
InventoryValuationReservesProvision
-274000 USD
CY2019Q1 aaon Inventory Valuation Reserves Provision
InventoryValuationReservesProvision
357000 USD
CY2020Q1 aaon Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
5000 USD
CY2019Q1 aaon Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
0 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2365000 USD
CY2019Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1567000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
59000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
700000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
700000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
487000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
428000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
213000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
272000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
59000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3024000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
353000 USD
CY2020Q1 aaon Changein Capital Expenditures Incurred But Not Yet Paid
ChangeinCapitalExpendituresIncurredButNotYetPaid
-1000000 USD
CY2019Q1 aaon Changein Capital Expenditures Incurred But Not Yet Paid
ChangeinCapitalExpendituresIncurredButNotYetPaid
1068000 USD
CY2020Q1 aaon Product Warranty Accrual Minimum Length
ProductWarrantyAccrualMinimumLength
P1Y
CY2020Q1 aaon Product Warranty Accrual Maximum Length
ProductWarrantyAccrualMaximumLength
P25Y
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12652000 USD
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11421000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1177000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1106000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1465000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1109000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12940000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11424000 USD
CY2020Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
1465000 USD
CY2019Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
1109000 USD
CY2020Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
12940000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
12652000 USD
CY2020Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
13123000 USD
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
11538000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6460000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5058000 USD
CY2020Q1 aaon Accrued Profit Sharing Current
AccruedProfitSharingCurrent
3167000 USD
CY2019Q4 aaon Accrued Profit Sharing Current
AccruedProfitSharingCurrent
1721000 USD
CY2020Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
480000 USD
CY2019Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
522000 USD
CY2020Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
1066000 USD
CY2019Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
707000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2256000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4627000 USD
CY2020Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
1450000 USD
CY2019Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
0 USD
CY2020Q1 aaon Donations Current
DonationsCurrent
354000 USD
CY2019Q4 aaon Donations Current
DonationsCurrent
354000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
2346000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
CY2020Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4017000 USD
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3804000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3025000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3286000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
909000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50684000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44269000 USD
CY2020Q1 aaon Actual Net Worth For Compliance
ActualNetWorthForCompliance
306300000 USD
CY2020Q1 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
175000000.0 USD
CY2020Q1 aaon Ratio Of Total Liability To Net Worth
RatioOfTotalLiabilityToNetWorth
0.3
CY2020Q1 aaon Maximum Ratio Of Total Liability To Net Worth Required For Compliance
MaximumRatioOfTotalLiabilityToNetWorthRequiredForCompliance
2
CY2020Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6143000 USD
CY2019Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1786000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-167000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5976000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2695000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.052
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.061
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.038
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.027
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.009
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.009
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.215
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235
CY2020Q1 aaon Expected Effective Income Tax Rate Continuing Operations
ExpectedEffectiveIncomeTaxRateContinuingOperations
0.25
CY2020Q1 aaon Cares Act Percent Of First Year Bonus Depreciation
CARESActPercentOfFirstYearBonusDepreciation
1
CY2020Q1 aaon Cares Act Percent Of First Year Bonus Depreciation
CARESActPercentOfFirstYearBonusDepreciation
1
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6400000 shares
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
28300000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y7M6D
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1024276 shares
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y3D
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
32.73
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15968000 USD
CY2019Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
683489 shares
CY2019Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2019Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
26.11
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13718000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3627047 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
36.32
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
939600 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.32
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
154335 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
29.13
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
38316 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
38.86
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4373996 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.27
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1024276 shares
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
32.73
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3900000 USD
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2100000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4500000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000000.0 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
267484 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
34.42
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
58840 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
42.65
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
62292 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
30.71
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
1120 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
35.88
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
262912 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
37.13
CY2020Q1 aaon Share Based Compensation Arrangement By Share Based Payment Award Options Awarded In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardedInPeriodFairValue
10905000 USD
CY2019Q1 aaon Share Based Compensation Arrangement By Share Based Payment Award Options Awarded In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardedInPeriodFairValue
19944000 USD
CY2020Q1 aaon Share Based Compensation Arrangement By Share Based Payment Award Restriced Stock Awarded In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestricedStockAwardedInPeriodFairValue
2510000 USD
CY2019Q1 aaon Share Based Compensation Arrangement By Share Based Payment Award Restriced Stock Awarded In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestricedStockAwardedInPeriodFairValue
3708000 USD
CY2020Q1 aaon Share Based Compensation Arrangement By Share Based Payment Award Total Awarded In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalAwardedInPeriodFairValue
13415000 USD
CY2019Q1 aaon Share Based Compensation Arrangement By Share Based Payment Award Total Awarded In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalAwardedInPeriodFairValue
23652000 USD
CY2020Q1 aaon Allocated Share Based Compensation Expense Stock Options
AllocatedShareBasedCompensationExpenseStockOptions
1632000 USD
CY2019Q1 aaon Allocated Share Based Compensation Expense Stock Options
AllocatedShareBasedCompensationExpenseStockOptions
4622000 USD
CY2020Q1 aaon Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
719000 USD
CY2019Q1 aaon Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
785000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2351000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5407000 USD
CY2020Q1 aaon Employee Service Share Based Compensation Tax Benefit From Compensation Expense Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpenseStockOptions
731000 USD
CY2019Q1 aaon Employee Service Share Based Compensation Tax Benefit From Compensation Expense Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpenseStockOptions
243000 USD
CY2020Q1 aaon Employee Service Share Based Compensation Tax Expense Benefit From Compensation Expense Restricted Stock
EmployeeServiceShareBasedCompensationTaxExpenseBenefitFromCompensationExpenseRestrictedStock
334000 USD
CY2019Q1 aaon Employee Service Share Based Compensation Tax Expense Benefit From Compensation Expense Restricted Stock
EmployeeServiceShareBasedCompensationTaxExpenseBenefitFromCompensationExpenseRestrictedStock
151000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1065000 USD
CY2019Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
394000 USD
CY2020Q1 aaon Definedcontributionemployeeautomaticcontributionpercentag
Definedcontributionemployeeautomaticcontributionpercentag
0.06
CY2020Q1 aaon Definedcontributionemployeeautomaticcontributionpercentag
Definedcontributionemployeeautomaticcontributionpercentag
0.06
CY2020Q1 aaon Definedcontributionemployeeautomaticcontributionpercentag
Definedcontributionemployeeautomaticcontributionpercentag
0.06
CY2020Q1 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
0 USD
CY2019Q1 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
0 USD
CY2019Q1 aaon Defined Benefit Plan Medical Claim Payments
DefinedBenefitPlanMedicalClaimPayments
1520000 USD
CY2020Q1 aaon Defined Benefit Plan Heath Saving Account Payments
DefinedBenefitPlanHeathSavingAccountPayments
874000 USD
CY2020Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2450000 USD
CY2019Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1360000 USD
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51992150 shares
CY2020Q1 aaon Profit Sharing Percentof Pretax Profit Paidto Eligible Employeeson Quarterly Basis
ProfitSharingPercentofPretaxProfitPaidtoEligibleEmployeesonQuarterlyBasis
0.10
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3167000 USD
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1306000 USD
CY2020Q1 aaon Defined Benefit Plan Medical Claim Payments
DefinedBenefitPlanMedicalClaimPayments
1875000 USD
CY2019Q1 aaon Defined Benefit Plan Heath Saving Account Payments
DefinedBenefitPlanHeathSavingAccountPayments
720000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52071839 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
799580 shares
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
377510 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52871419 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52369660 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
253437 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1927727 shares
CY2018Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 USD
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
246460 shares
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12518000 USD
CY2020Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
50.79
CY2019Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
128504 shares
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5071000 USD
CY2019Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
39.46
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
13797694 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
221833000 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
16.08
CY2019Q1 aaon Contractual Obligation Numberof Contracts
ContractualObligationNumberofContracts
1 contract
CY2020Q1 us-gaap Contractual Obligation
ContractualObligation
1800000 USD
CY2020Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
653000 USD
CY2019Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
50000 USD
CY2020Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
59000 USD
CY2019Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
127000 USD
CY2020Q1 us-gaap Due From Related Parties
DueFromRelatedParties
478000 USD
CY2019Q4 us-gaap Due From Related Parties
DueFromRelatedParties
22000 USD
CY2020Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 USD
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
2000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
137483000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
113822000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
42947000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
25430000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
113822000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
88392000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
25430000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13677000 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-284000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11469000 USD
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11452000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2695000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51992150 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52369660 shares
CY2019Q1 us-gaap Assets Current
AssetsCurrent
146511000 USD
CY2019Q1 us-gaap Assets
Assets
319238000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
43082000 USD
CY2019Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10168000 USD
CY2019Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3442000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
262546000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249443000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4010000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5407000 USD
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
5071000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
262546000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8757000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5914000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
115000 USD
CY2019Q1 us-gaap Inventory Write Down
InventoryWriteDown
357000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5407000 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-284000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
16000 USD
CY2019Q1 aaon Interest Income Note Receivable
InterestIncomeNoteReceivable
6000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
909000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4725000 USD
CY2019Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
1432000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2678000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
561000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5730000 USD
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
73000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14913000 USD
CY2019Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8772000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
52000 USD
CY2019Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
17000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8703000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4010000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
4483000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
588000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1061000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5149000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1994000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7143000 USD

Files In Submission

Name View Source Status
0000824142-20-000090-index-headers.html Edgar Link pending
0000824142-20-000090-index.html Edgar Link pending
0000824142-20-000090.txt Edgar Link pending
0000824142-20-000090-xbrl.zip Edgar Link pending
aaon-20200331.htm Edgar Link pending
aaon-20200331.xsd Edgar Link pending
aaon-20200331_cal.xml Edgar Link unprocessable
aaon-20200331_def.xml Edgar Link unprocessable
aaon-20200331_htm.xml Edgar Link completed
aaon-20200331_lab.xml Edgar Link unprocessable
aaon-20200331_pre.xml Edgar Link unprocessable
aaon10q033120ex311.htm Edgar Link pending
aaon10q033120ex312.htm Edgar Link pending
aaon10q033120ex321.htm Edgar Link pending
aaon10q033120ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending